TY - JOUR T1 - Evaluating the effects of re-opening plans on dynamics of COVID-19 in São Paulo, Brazil<sup>1</sup> JF - medRxiv DO - 10.1101/2021.01.14.21249809 SP - 2021.01.14.21249809 AU - F.A. Rubio AU - T.N. Vilches Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/15/2021.01.14.21249809.abstract N2 - Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization in early March 2020. In Brazil, São Paulo is the most affected state, comprising about 20% of the country’s cases. With no vaccine available to date, distancing measures have been taken to reduce virus transmission. To reduce the pandemic’s effect on the economy, the government of São Paulo has proposed a plan consisting of five phases of the gradual re-opening of activities. In this context, we have developed a mathematical model to simulate the gradual re-opening plan on the transmission dynamics of COVID-19, in the city of São Paulo. The model shows that a precipitous reopening can cause a higher peak of the disease, which may compromise the local health system. Waiting for the reduction in the incidence of infected individuals for at least 15 days to phase transition is the most efficient strategy compared to the fixed-period scenario at each phase of the re-opening plan.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTNV thanks to Sao Paulo Research Fundation for the finantial support (grant \#2018/24811-1). FAR thanks the Coordination of Superior Level Staff Improvement (CAPES) for the financial support (Finance Code 001)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This paper does not include animal and/or human trialsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available officially by the government of São Paulo https://www.saopaulo.sp.gov.br/coronavirus/isolamento/ ER -